ZALEVSKY JONATHAN (Chief R&D Officer) sold 1.9% of their position (186.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0001193125-26-359588
Officer· Chief R&D Officer
Since Oct 2019
-186.00
Net shares
Net seller
$13.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
186.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−186.00
Price / share
$71.98
Trade value
$13.39K
% of position
1.9%
8/18/2026
9.76K→9.57K
Total
Net shares
−186.00
Net value
-$13.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −186.00 | $71.98 | $13.39K | 1.9% | 9.76K | 9.57K |
| Total | −186.00 | -$13.39K | ||||||
Derivative Transactions0
No derivative transactions reported